LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · IEX Real-Time Price · USD
15.53
-0.33 (-2.08%)
Apr 25, 2024, 12:59 PM EDT - Market open
LENZ Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for LENZ Therapeutics stock have an average target of 31.33, with a low estimate of 28 and a high estimate of 34. The average target predicts an increase of 101.74% from the current stock price of 15.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LENZ stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 |
|---|---|
| Strong Buy | 1 |
| Buy | 3 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $32 | Buy | Initiates | $32 | +106.05% | Apr 15, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 15, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +118.93% | Apr 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $28 | Buy | Initiates | $28 | +80.30% | Mar 27, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.55M
EPS This Year
-1.80
from -15.33
EPS Next Year
-2.28
from -1.80
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 12.9M | 66.2M |
| Avg | n/a | 12.5M | 64.3M |
| Low | n/a | 12.1M | 61.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 427.3% |
| Avg | - | - | 412.2% |
| Low | - | - | 392.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.85 | -2.35 | -1.38 |
| Avg | -1.80 | -2.28 | -1.34 |
| Low | -1.72 | -2.20 | -1.28 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.